GF Fund Management’s Revance Therapeutics, Inc. RVNC Stock Holding History

GF Fund Management’s Portfolio RVNC Stock Details RVNC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-2,203	Closed	-$6.7K	–	683
2024 Q4	$6.7K	Buy	+2,203	New	+$9.6K	﹤0.01%	593

Other funds holding RVNC

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

GF Fund Management's RVNC Position: Q1 2025 in Review

GF Fund Management sold out of Revance Therapeutics, Inc. (RVNC) in Q1 2025, closing a stake of 2,203 shares — an estimated $6.7K sold.

GF Fund Management first reported a position in RVNC in Q4 2024 and held it in 1 quarter. The position peaked at $6.7K in Q4 2024. 1 fund tracked by Wall St. Rank holds RVNC as of Q1 2025.

GF Fund Management reported no remaining Revance Therapeutics, Inc. position as of Q1 2025 after selling out during the quarter.
GF Fund Management sold 2,203 Revance Therapeutics, Inc. shares in Q1 2025, an estimated $6.7K.
GF Fund Management first reported a position in Revance Therapeutics, Inc. in Q4 2024 and held it in 1 quarter.
GF Fund Management's Revance Therapeutics, Inc. position peaked at $6.7K in Q4 2024.
1 fund tracked by Wall St. Rank held Revance Therapeutics, Inc. as of Q1 2025.

Based on GF Fund Management's 13F filing for Q1 2025, filed 29 Apr 2025.